GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (WBO:PFE) » Definitions » E10

Pfizer (WBO:PFE) E10 : €2.48 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pfizer E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Sep. 2024 was €0.703. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €2.48 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Pfizer's average E10 Growth Rate was -2.80% per year. During the past 3 years, the average E10 Growth Rate was 8.30% per year. During the past 5 years, the average E10 Growth Rate was 9.20% per year. During the past 10 years, the average E10 Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pfizer was 20.10% per year. The lowest was -4.10% per year. And the median was 9.90% per year.

As of today (2024-12-13), Pfizer's current stock price is €24.095. Pfizer's E10 for the quarter that ended in Sep. 2024 was €2.48. Pfizer's Shiller PE Ratio of today is 9.72.

During the past 13 years, the highest Shiller PE Ratio of Pfizer was 24.28. The lowest was 8.99. And the median was 17.76.


Pfizer E10 Historical Data

The historical data trend for Pfizer's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer E10 Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 1.76 2.18 2.80 2.47

Pfizer Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 2.47 2.58 2.55 2.48

Competitive Comparison of Pfizer's E10

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.703/133.0289*133.0289
=0.703

Current CPI (Sep. 2024) = 133.0289.

Pfizer Quarterly Data

per share eps CPI Adj_EPS
201412 0.154 99.070 0.207
201503 0.351 99.621 0.469
201506 0.374 100.684 0.494
201509 0.303 100.392 0.402
201512 -0.028 99.792 -0.037
201603 0.440 100.470 0.583
201606 0.294 101.688 0.385
201609 0.196 101.861 0.256
201612 0.123 101.863 0.161
201703 0.477 102.862 0.617
201706 0.454 103.349 0.584
201709 0.394 104.136 0.503
201712 1.707 104.011 2.183
201803 0.478 105.290 0.604
201806 0.556 106.317 0.696
201809 0.591 106.507 0.738
201812 -0.062 105.998 -0.078
201903 0.602 107.251 0.747
201906 0.788 108.070 0.970
201909 1.235 108.329 1.517
201912 -0.054 108.420 -0.066
202003 0.543 108.902 0.663
202006 0.551 108.767 0.674
202009 0.221 109.815 0.268
202012 0.082 109.897 0.099
202103 0.722 111.754 0.859
202106 0.813 114.631 0.943
202109 1.207 115.734 1.387
202112 0.522 117.630 0.590
202203 1.244 121.301 1.364
202206 1.637 125.017 1.742
202209 1.525 125.227 1.620
202212 0.821 125.222 0.872
202303 0.906 127.348 0.946
202306 0.378 128.729 0.391
202309 -0.394 129.860 -0.404
202312 -0.550 129.419 -0.565
202403 0.506 131.776 0.511
202406 0.009 132.554 0.009
202409 0.703 133.029 0.703

Add all the adjusted EPS together and divide 10 will get our e10.


Pfizer  (WBO:PFE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=24.095/2.48
=9.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pfizer was 24.28. The lowest was 8.99. And the median was 17.76.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pfizer E10 Related Terms

Thank you for viewing the detailed overview of Pfizer's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.